Melanotan I
FDA ApprovedMelanotan I (Afamelanotide)
- Category
- Aesthetic & Beauty
- Aliases
- Afamelanotide, Scenesse
- Administration
- Subcutaneous implant (FDA-approved route)
Timing
A general projection of what people report noticing over time, based on the known mechanism and reported use patterns. It is not a guarantee and individual experience varies considerably.
- 1
1–2 Weeks
In its approved implant form, users typically notice increased sun tolerance within the first couple of weeks.
- 2
3–4 Weeks
Skin pigmentation changes are commonly visible by this stage.
- 3
5–7 Weeks
The effects of a single implant are generally expected to remain steady through this window.
- 4
8–10 Weeks
Sun tolerance and pigmentation benefits typically continue through the implant's roughly two-month duration.
- 5
11–15 Weeks
A second implant is commonly administered around this time to maintain effects, per approved dosing.
- 6
16–20 Weeks
With repeat dosing, users typically report consistent, maintained photoprotection.
- 7
21–24 Weeks
By this stage, most patients on approved therapy are in a steady maintenance pattern.
⚠️ Research context only. This is not medical advice and results are not guaranteed.